Syros Pharmaceuticals Gave Notice To Qiagen Manchester Limited Of Its Election To Terminate The Master Collaboration Agreement Dated March 7, 2022

BenzingaNov 18 07:34 ET

Syros Pharmaceuticals Faces Financial Struggles Amid Key Challenges

TipRanksNov 18 07:27 ET

Express News | Syros Pharmaceuticals Inc - Appointment of Gerald Quirk, Esq., as President & CEO

ReutersNov 18 07:11 ET

Express News | Syros - Notified Conley Chee,CEO ,Jason Haas,CFO, David Roth, Chief Medical Officer That Employment of Such Officers Will Terminate Without Cause

ReutersNov 18 07:10 ET

Express News | Syros Pharmaceuticals Inc - Committed to Implementing a Reduction in Workforce by Approximately 94%

ReutersNov 18 07:05 ET

Express News | Syros Pharmaceuticals Inc - on Nov 15, Paid $33.5 Mln to Oxford in Partial Satisfaction of Its Obligations Under Loan Agreement

ReutersNov 18 07:05 ET